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The effect of C60 fullerene aqueous colloid solution (C60FAS) on the intensity of long‑lasting (persisting for one hour) rotational 
movements in non‑anesthetized rats was investigated. For this purpose, an experimental hemiparkinsonic animal model was 
used in the study. Rotational movements in hemiparkinsonic animals were initiated by the intraperitoneal administration of the 
dopamine receptor agonist apomorphine. It was shown that a preliminary injection of C60FAS (a substance with powerful antioxidant 
properties) in hemiparkinsonic rats induced distinct changes in animal motor behavior. It was revealed that fullerene‑pretreated 
animals, in comparison with non‑pretreated or vehicle‑pretreated rats, rotated for 1 h at an approximately identical speed until 
the end of the experiment, whereas the rotation speed of control rats gradually decreased to 20–30% of the initial value. One can 
assume that the observed changes in the movement dynamics of the hemiparkinsonic rats after C60FAS pretreatment presumably 
can be induced by the influence of C60FAS on the dopaminergic system, although the isolated potentiation of the action of 
apomorphine C60FAS cannot be excluded. Nevertheless, earlier data on the action of C60FAS on muscle dynamics has suggested 
that C60FAS can activate a protective action of the antioxidant system in response to long‑lasting muscular activity and that the 
antioxidant system in turn may directly decrease fatigue‑related changes during long‑lasting muscular activity.
Key words: C60 fullerene nanoparticles, non‑anesthetized animals, skeletal muscle fatigue, hemiparkinsonic animal model, 
dopamine, rat
INTRODUCTION
Skeletal muscles have large energy reserves for 
long‑term contractions, but excessive physical activi‑
ty leads to reduced muscle force contractions and fa‑
tigue development. Long‑lasting and intense muscle 
contraction associated with physical activity or work is 
often accompanied by muscular pain, posture impair‑
ment and motor control disruption (Gandevia, 2001; 
Ervilha et al., 2005). In the process of muscle fatigue 
development, a violation of metabolism and the forma‑
tion of products that result from the incomplete oxi‑
dation of oxygen, such as peroxide, free radicals, and 
oxygen ions, occur. The increased production of mus‑
cle‑derived reactive oxygen species (ROS) is involved 
in the development of muscle fatigue and the mecha‑
nism of prolonged contractile activity‑induced muscle 
damage (Pinheiro et al., 2012). The damage can include 
changes in protein structures, nitrogenous bases, and 
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the destruction of membranes (Powers et al., 2008). 
Cell protection during such injury is provided by the 
antioxidant system (Banerjee et al., 2003). Although 
the mechanisms of skeletal muscle fatigue have been 
described in detail (Boyas and Guével, 2011), the prob‑
lem of preventing or correcting muscle fatigue remains 
unresolved. In studies of muscle fatigue, endogenous 
antioxidants, such as N‑acetylcysteine and β‑alanine, 
are widely used and speed up the muscle recovery pro‑
cess after fatigue (Reid et al., 1994; Harris and Sale, 
2012). Recently, it was shown that bioactive soluble 
carbon nanostructures, such as pristine C60 fullerenes, 
may be used as potential antioxidants (Gharbi et al., 
2005). It is important that low and even high doses of 
such fullerenes do not present any acute or subacute 
toxicity in the animals; the maximum tolerated dose 
of C60 fullerene for both oral and intraperitoneal (i.p.) 
administration in rats was found to be 5 g/kg (Gharbi 
et al., 2005). In our previous electrophysiological and 
biochemical study, we investigated the effect of pris‑
tine C60 fullerene aqueous colloid solution (C60FAS) on 
fatigue of triceps surae (TS) muscles in rats induced 
by the intermittent high‑frequency electrical stimula‑
tion of the tibial nerve. It was shown that the use of 
C60FAS led to a reduction in the recovery time of muscle 
contraction force and an increase in the time of active 
work in muscles during fatigue development in anes‑
thetized Wistar rats (Prylutskyy at al. 2017; Vereshcha‑
ka at al. 2018). However, these studies were carried out 
on anesthetized animals and only on the TS. The effect 
of C60FAS on the development of general muscle fatigue 
in non‑anesthetized animals has not yet been studied. 
It is known that animals with experimental hemipar‑
kinsonism (EH) exhibit circular movements (Maisky et 
al., 2002; Talanov et al., 2017). We hypothesized that an 
EH animal model can be used to assess the development 
and modulation of skeletal muscle fatigue in non‑anes‑
thetized rats. That is, the i.p. injection of the dopamine 
(DA) receptor agonist apomorphine (AM), which induc‑
es long‑lasting circular movements in hemiparkinsonic 
animals, can lead to skeletal muscle fatigue, and us‑
ing C60 fullerene as a powerful antioxidant will induce 
changes in the movement of the rats for 1 h. Thus, the 
aim of this study was to reveal the preventive effect 
of C60FAS on the development of muscle fatigue during 
long‑lasting rotational movements induced by AM in 
non‑anesthetized animals with EH.
METHODS
Male Wistar rats weighing 260–330 g were used in 
the study. The experimental animals were housed in 
Plexiglas cages and kept in an air‑filtered and tempera‑
ture‑controlled (21±1°C) room under 12‑h light/12‑h 
dark conditions. Rats received a standard pellet diet and 
water ad libitum. The use of the animals was approved 
by the Ethics Committee of the Institute and performed 
in accordance with the European Communities Council 
Directive of 24 November 1986 (86/609/EEC).
Stereotaxic surgery and behavioral assessment
Unilateral lesions of mesolimbic and nigrostriatal 
dopaminergic neurons were induced in rats by intra‑
cerebrally injecting the selective neurotoxin 6‑hy‑
droxydopamine (6‑OHDA, 8 μg, Sigma, USA) into the 
left medial forebrain bundle, and these lesions result‑
ed in hemiparkinsonism (Maisky et al., 2002). The co‑
ordinates for the 6‑OHDA injections were determined 
according to stereotaxic coordinates of the rat brain 
(Paxinos and Watson, 1997). The following coordinates 
were used: anteroposterior from bregma (AP)=‑2.2 mm, 
mediolateral from the midline (ML)=+1.5 mm and dor‑
soventral from the dura mater (DV)=‑8.0 mm. The tooth 
bar was located 4.5 mm above the interaural line. 
6‑OHDA was dissolved in 4 μl of 0.9% ice‑cold saline 
with 0.1% ascorbic acid to prevent the oxidation of the 
neurotoxin and injected using glass micropipettes (tip 
diameter of 80–100 μm) attached to a microsyringe. 
Pargyline administration (40 mg/kg, i.p., Sigma, USA) 
was performed 30 min before neurotoxin injection to 
inhibit the metabolic transformation of the neurotox‑
in by monoamine oxidase. In addition, desipramine 
(25 mg/kg, i.p., Sigma, USA) was injected to block the 
uptake of 6‑OHDA by noradrenergic neurons (Maisky 
et al., 2002). Stereotaxic surgery was performed under 
sodium pentobarbital (45 mg/kg, i.p., Nembutal, USA) 
anesthesia. Experimental animals were screened 7 days 
after 6‑OHDA administration with an i.p. injection of 
AM (0.5 mg/kg, Sigma, USA) to verify the efficiency of 
the lesion. Application of the AM should induce contra‑
lateral rotational movements in animals with lesions 
in the nigrostriatal DA system (Kirik et al., 1998). Only 
animals that exhibited >180 rotations per 30 min period 
immediately following the injection of AM were used 
in the study. It indicates a decrease in the number of 
DAergic neurons in the pars compacta of the substantia 
nigra (SN) and ventral tegmental area (VTA) in the left 
hemisphere by 96.6% and 92.1%, respectively (Maisky 
et al., 2002).
Experimental groups
After 7 days of 6‑OHDA administration, all animals 
were randomly divided into 3 groups: non‑pretreated 
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rats (control animals that only received AM (0.5 mg/kg, 
Sigma, USA, n=6) i.p.; vehicle‑pretreated rats (animals 
that received saline solution (0.3 ml per animal) i.p. 
60 min prior to AM injection, n=6); and fullerene‑pre‑
treated rats (animals that received C60FAS (0.3 ml, 
0.14 mg/kg) i.p. 60 min prior to AM injection, n=6). To 
avoid AM addiction, the experimental procedure was 
carried out in each animal once a week. A general over‑
view of the experiment is shown in Fig. 1A, B.
Material preparation and characterization
A highly stable C60FAS with a purity of more than 
99.96% was prepared and characterized (Ritter et al., 
2015) in the Institute of Chemistry and Biotechnology, 
Technical University of Ilmenau (Germany). The meth‑
od is based on transferring C60 fullerenes from organic 
solution into the aqueous phase by ultrasonic treatment. 
The purity of the prepared C60FAS (i.e., the presence/ab‑
sence of any residual impurities such as carbon black 
and toluene phase) was determined by high‑perfor‑
mance liquid chromatography (HPLC) and GC/MS anal‑
ysis (Keykhosravi et al., 2019). The state of C60 fullerene 
in aqueous solution was monitored using atomic force 
microscopy (AFM “Solver Pro M” system, NT‑MDT, Rus‑
sia) as well as the dynamic light scattering (DLS) method 
(Zetasizer Nano‑ZS90, Malvern, Worcestershire, UK) at 
room temperature. The AFM study of prepared C60FAS 
revealed that the majority of C60 molecules were locat‑
ed chaotically and separately along the surface (see the 
dotted objects with a height of ~0.7 nm in Fig. 2), or in 
the form of bulk nanoclusters consisting of several mol‑
ecules (objects with a height of 1.3–2 nm in Fig. 2). The 
Fig. 1. Schematic representation of the experiment. The site of selective neurotoxin 6‑hydroxydopamine (6‑OHDA) administration (‑2.2 mm caudal to 
bregma) at the level of brain structures (A) according to the stereotaxic coordinates of the rat brain (Paxinos and Watson, 1997). Experimental schedule: 
7 days after 6‑OHDA administration (B): 1 – preliminary i.p. injection of saline solution or C60 fullerene; 2 – i.p. injection of apomorphine; 3 – animal rotation 
counts. Structures: mfb – medial forebrain bundle; 3V – 3rd ventricle.
Fig.  2. AFM image of the single C60 fullerene (~0.7  nm) and its bulk 
nanoclusters (1.3–2 nm) on a freshly broken surface of mica (semicontact 
(tapping) mode).
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formation of large C60 fullerene nanoclusters in aqueous 
solution was confirmed by DLS measurements: the mean 
hydrodynamic diameter of light scattering nanopar‑
ticles equaled 82 nm, and the value of zeta potential 
was ‑23.9 mV, that indicates a high stability of the used 
C60FAS. The maximal concentration of C60 fullerenes in 
water obtained by this method was 0.15 mg/ml.
Statistical analysis
Six rats participated in 6 experiments, and the ob‑
tained data were averaged for each animal. The number 
of rotations induced by the injection of AM was also 
averaged every 6 min for an hour (1‑6 min, 7‑12 min, 
13‑18 min, 19‑24 min, 25‑30 min, 31‑36 min, 37‑42 min, 
43‑48 min, 49‑54 and 55‑60 min) and were normalized. 
The values are expressed as the mean ± standard er‑
ror of the mean (S.E.M.) and were analyzed by one‑way 
ANOVA. The factors of variation included two condi‑
tions: time and animal group. Values of P<0.05 were 
considered significant. Bonferroni post hoc analysis was 
used when a significant difference was detected.
RESULTS
In the course of the research, it was found that in 
response to AM administration, the non‑pretreat‑
ed group of rats exhibited rotational movements for 
60 min at different speeds and with a tendency to 
continuously decrease in speed. On average, the ani‑
mals began to rotate at a speed of 10–18 rotations per 
minute (rpm), and the rotations gradually decreased 
to the end of the experiment to 2–5 rpm and even to 
a complete stop; that is, the average number of rats 
revolutions decreased to 20–30%. The rats in the vehi‑
cle‑pretreated group demonstrated similar results. For 
example, after AM injection, one rat from group 1 start 
rotating at a speed of 13.3 ± 1.96 rpm (average of 6 ex‑
periments) and finished an hour later at a speed of 5.16 
± 0.7 rpm. One rat from group 2 start rotating at a speed 
of 13.8 ± 0.7 and finished at a speed of 5.9 ± 2.8 rpm 
(Fig. 3A). The total number of rotations (in one hour) 
for these rats was 557 and 585, respectively. It should 
be noted that there was no significant difference in the 
mean number of rotations performed by the rats from 
group 1 and the rats from group 2 (Fig. 3B). The animals 
from the third group, which were previously adminis‑
tered C60FAS, in response to the AM induction, began 
to rotate at a similar rate as the rats from groups 1 and 
2. In the first 12 min, there was a 15–20% decrease in 
the mean number of rotations; after that, the intensity 
of the rotational movements gradually increased and 
reached the initial values or even exceeded them by 
5–10% in some animals by the end of the experiment. 
For instance, one rat from the fullerene‑pretreated 
group (after AM injection) start rotate at a speed of 13.6 
± 2.06 rpm and finished an hour later at a speed of 16.16 
± 0.94 rpm, exhibiting total of 801 rotations. One‑way 
Fig. 3. Mean number ± S.E.M. of rotations per minute (rpm, averaged over 6 min) performed by non‑pretreated, vehicle‑pretreated and fullerene‑pretreated 
rats (A). Each curve in the diagram corresponds to the values obtained from one animal and averaged over 6 experiments. Average group characteristics 
(mean ± S.E.M.) of normalized  rpm values (with respect to the average  rpm values in the first six  min) in non‑pretreated, vehicle‑pretreated and 
fullerene‑pretreated rats (B).
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ANOVA was used to determine the effect of C60FAS. Bon‑
ferroni post hoc analysis revealed a significant (P<0.001) 
increase in the mean number of rotations exhibited by 
the rats from group 3 in comparison with the animals 
from groups 1 and 2 beginning 13 min after the injec‑
tion of AM (13–18 min (F2,105=7.54, P<0.001), 19–24 min 
(F2,105=14.47, P<0.001), 25–30 min (F2,105=37.15, P<0.001), 
31–36 min (F2,105=27.34, P<0.001), 37–42 min (F2,105=59.02, 
P<0.001), 43–48 min (F2,105=59.45, P< 0.001), 49–54 min 
(F2,105=115.57, P<0.001) and 55–60 min (F2,105=185.46, 
P<0.001) (Fig. 2).
DISCUSSION
The obtained results showed a significant increase 
in the number of rotations exhibited by the animals 
from the fullerene‑pretreated group in comparison 
with the non‑pretreated and vehicle‑pretreated rats. 
It is known that, after long‑lasting muscle activity, 
metabolism is significantly increased in the muscles, 
and this increase leads to the accumulation of second‑
ary oxidation products in muscle fibres and further fa‑
tigue development (Casey and Joyner, 2011). The flow 
of oxygen through muscle cells is greatly increased 
due to intense muscle activity. High levels of oxygen 
uptake can lead to excessive ROS generation and have 
been implicated in muscle soreness and myofibril dis‑
ruption (Clanton et al., 1999). In our previous findings 
(Vereshchaka et al., 2018), a significant decrease in 
the force contraction of the TS muscle induced by the 
intermittent electrical stimulation of the tibial nerve 
was shown. However, animals previously treated with 
C60FAS demonstrated an increase in the time of active 
work of muscles until fatigue development. In addi‑
tion, our biochemical study revealed a significant in‑
crease in thiobarbituric acid reactive substances and 
hydrogen peroxide content in fatigue development 
that led to an increase in catalase (CAT) activity and 
reduced glutathione (GSH) content in the TS muscle 
fibers. After C60FAS administration under fatigue de‑
velopment, GSH content and CAT activity were signifi‑
cantly reduced compared to those in the control. It is 
assumed that C60FAS affects the content and activity 
of endogenous antioxidants and can, to a certain ex‑
tent, prevent fatigue in actively contracting muscles, 
thereby maintaining their normal physiological states 
(Vereshchaka et al., 2018). It is known that the en‑
hancement of free radical processes is the main patho‑
genic factor in the development of skeletal muscle 
fatigue (Lee et al., 2014). With considerable physical 
activity, there is a robust overproduction of free rad‑
icals in muscle tissue (Clarkson and Thompson, 2000). 
Using exogenous antioxidants of different natures 
leads to a significant decrease in skeletal muscle fa‑
tigue during intense physical activity and increases 
the time of muscle fatigue onset during prolonged in‑
tense loads (Ferreira and Reid, 2008; Mach et al., 2010; 
Hong et al., 2015). These data demonstrate the feas‑
ibility of using antioxidants for correcting the level 
of oxidative stress in muscle tissue during extreme 
conditions and increasing its efficiency. By comparing 
the behavioral performance of the rats from the three 
groups, it can be assumed that the decrease in the 
number of rotations exhibited by the animals from the 
non‑pretreated and vehicle‑pretreated groups was not 
due to the termination of the effect of apomorphine 
but rather the development of muscle fatigue during 
long‑lasting rotational movements. At the same time, 
after the application of C60FAS, a decrease in the aver‑
age number of rotations was not observed in the rats 
from the third group. Presumably, this effect is relat‑
ed to the effect of C60FAS on the dopaminergic system 
in the brain, although the enhancement of the effect 
of AM by C60FAS cannot excluded. However, based on 
our previous studies (Prylutskyy at al., 2017; Veresh‑
chaka at al., 2018) we assume that the observed effect 
indicates the activation of the protective effect of the 
antioxidant system in response to long‑lasting muscle 
activity, and C60FAS can be considered a powerful acti‑
vator of protective mechanisms aimed at reducing 
skeletal muscle fatigue.
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